1Ministry of Labour and Social Security, Ankara, Turkey (Correspondence to R. Güven: [email protected]). 2Department of Public Health, Faculty of Medicine, Hacettepe University, Ankara, Turkey. Received: 17/02/04; accepted: 11/04/05 ABSTRACT Turkey is an intermediate endemic area for hepatitis B virus infection. The study investigated the hepatitis B exposure risk and prevalence of hepatitis B...

Many Vaccine Information Statements are available in Spanish and other languages. See www.immunize.org/vis. 1 What is hepatitis B? Hepatitis B is a serious disease that affects the liver. It is caused by the hepatitis B virus (HBV). HBV can cause: Acute (short-term) illness. This can lead to: • loss of appetite • diarrhea and vomiting • tiredness • jaundice (yellow skin or eyes) • pain in muscl...

Hepatitis D, also referred to as hepatitis D virus, or delta virus (HDV) is considered be a subviral satellite because it can propagate only in the presence of B (HBV) (WHO, 2020). There are uncertainties about epidemic patterns HDV infection and its contribution burden liver disease. defective that completes life cycle with (HBV). The HBV super-infection has been one most severe forms chronic ...

background and objectives: vaccination is the major strategy to protect nurses against infection with hepatitis b virus. however, some nurses do not produce sufficient amount of anti-hbsag antibody required for immunity against infection. chronic occupational stress has been proposed as a risk factor to humoral immunity. given that nursing staff is exposed to occupational stress risk, this stud...

Hepatitis B infection remains a major public health problem globally and in the United States, with significant use of healthcare resources. Several therapeutic agents active against viral and host targets are currently available for its treatment. The success of combination therapy in HIV infection, which has similarities to hepatitis B in both therapeutic targets and treatment options, stimul...

Hepatitis B virus (HBV) is one of the major global public health problems.HBV infection 10th leading cause death.(1) In India, HBsAg prevalence,(an indicator chronic HBV infection) among general population ranges from 2% to 8%.(2) vaccination has been integrated in Universal Immunization Program (UIP) for last 10 years. All new borns are expected receive at 0 day and subsequently 6, 14 weeks.&#...

A 51-year-old man who was hepatitis B surface antigen (HBsAg)-negative and positive for anti-hepatitis B surface antigen (anti-HBs) and anti-hepatitis B core antigen (anti-HBc), during rituximab therapy for chronic Lymphocytic leukemia, developed reactivation of hepatitis B virus (HBV) infection with hepatitis that proceeded towards hepatic failure and death in spite of lamivudine therapy. HBsA...

Background/Aim: Hepatitis B surface antigen(HBsAg) is routinely detected qualitatively in Hepatitis B Virus(HBV) infection where its persistence beyond 6 months defines chronic hepatitis B(CHB) infection. Hepatitis B e antigen (HBeAg) usually indicates active HBV replication and risk of transmission of infection. In spite of the emerging use of chemiluminescence based quantitative HBsAg assays ...

OBJECTIVES To analyze the role of HLA genotypes in persistence of chronic hepatitis B in Western India. METHODS HLA genotyping for class II-DR was done in 26 subjects having chronic hepatitis B infection (HBsAg positive) and in 100 healthy controls. Statistics were done using Halden's modification of Woolf's formula. RESULT Significant association of chronic hepatitis B infection was found ...